NEW YORK (GenomeWeb) – Contextual Genomics and the Personalized Medicine Initiative today announced that Pfizer Canada has joined the National Access Project for Cancer Testing.

Pfizer Canada has provided a grant of an undisclosed amount and technical support as part of its commitment to the consortium, whose goal is to provide genomic testing to all Canadians diagnosed with cancer and to accelerate a personalized approach to treating the disease.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.